Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic training
{{output}}
Hodgkin lymphoma (HL) outcomes have improved due to advances in cancer treatment. However, HL survivors remain at increased risk for cardiovascular (CV) morbidity and mortality related to the long-term cardiotoxicity of HL treatment, particularly anthracycline... ...
